share_log

bluebird bio | 3: Initial statement of beneficial ownership of securities-Officer Sterling O. James

bluebird bio | 3: Initial statement of beneficial ownership of securities-Officer Sterling O. James

bluebird bio | 3:首次持股声明-高管 Sterling O. James
美股sec公告 ·  06/13 17:04
Moomoo AI 已提取核心信息
On June 10, 2024, Sterling O. James, the Chief Financial Officer of bluebird bio, Inc., filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as mandated by Section 16(a) of the Securities Exchange Act of 1934. The filing, which is a standard requirement for officers, directors, and certain beneficial owners of public companies, indicates that Sterling O. James does not beneficially own any securities in the company. The form was filed individually by James and was signed by Sydney Gaylin, Attorney-in-Fact, on June 13, 2024. This filing is part of the regulatory requirements that ensure transparency of ownership by key executives and is closely monitored by investors for any changes in ownership that might influence the company's stock performance.
On June 10, 2024, Sterling O. James, the Chief Financial Officer of bluebird bio, Inc., filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as mandated by Section 16(a) of the Securities Exchange Act of 1934. The filing, which is a standard requirement for officers, directors, and certain beneficial owners of public companies, indicates that Sterling O. James does not beneficially own any securities in the company. The form was filed individually by James and was signed by Sydney Gaylin, Attorney-in-Fact, on June 13, 2024. This filing is part of the regulatory requirements that ensure transparency of ownership by key executives and is closely monitored by investors for any changes in ownership that might influence the company's stock performance.
2024年6月10日,bluebird bio,Inc.的首席财务官Sterling O. James根据《证券交易法》第16(a)条的要求向证券交易委员会提交了一份有关证券受益所有权的初步声明。这种申报是对公共公司的管理人员、董事以及某些受益所有者的标准要求,表明Sterling O. James并不是该公司的任何证券品种的受益所有人。这个表格由James个人提交,并于2024年6月13日由Attorney-in-Fact Sydney Gaylin签名。这个申报是确保公司核心管理层的所有权透明的监管要求的一部分,对任何可能影响公司股票表现的所有权变化都有密切的投资者监控。
2024年6月10日,bluebird bio,Inc.的首席财务官Sterling O. James根据《证券交易法》第16(a)条的要求向证券交易委员会提交了一份有关证券受益所有权的初步声明。这种申报是对公共公司的管理人员、董事以及某些受益所有者的标准要求,表明Sterling O. James并不是该公司的任何证券品种的受益所有人。这个表格由James个人提交,并于2024年6月13日由Attorney-in-Fact Sydney Gaylin签名。这个申报是确保公司核心管理层的所有权透明的监管要求的一部分,对任何可能影响公司股票表现的所有权变化都有密切的投资者监控。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息